Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
New Capricor Data Reports 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002
BiotechStocktrader
-
May 8, 2020
0
Therma Bright Announces Closing of Over-Subscribed Private Placement for $1,250,000
Andrew M.
-
August 7, 2020
0
Orgenesis to Collaborate with Educell to Conduct Clinical Validation of Cell Therapies Using Orgenesis’ Proprietary POCare Technologies for the...
Andrew M.
-
July 14, 2020
0
Biotech News
Home
Biotech News
Biotech News
Big Pharma Dives Into CBD: Who Could Be Next?
Paul Archie
-
February 22, 2021
0
Biotech News
Guided Therapeutics Submits Clinical Study Protocol to U.S. FDA for LuViva®...
Guided Therapeutics, Inc.
-
July 28, 2020
0
Biotech News
BioSig Technologies (BSGM) PT Raised to $12.50 at Chardan Ahead of...
BiotechStocktrader
-
September 20, 2018
0
Biotech News
Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its...
Paul Archie
-
December 8, 2020
0
1
2
3
...
22
Page 1 of 22
- Advertisement -
APPLE
Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its...
Andrew M.
-
August 17, 2020
0
Biotech News
CRANFORD, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) today announced that its Board of Directors (the...
RECENT POSTS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Paul Archie
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Paul Archie
-
February 22, 2021
Clinical Trials Focus on COVID-19 and Acute Myocarditis
Paul Archie
-
January 19, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Paul Archie
-
December 22, 2020
